Insider Cluster (2 insiders) ·Filed Jul 2, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $148K total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading signal. Monitor for upcoming pipeline catalysts (Septerna is a clinical-stage biotech) and any material 8-K or press release that could move the stock. The director grants are standard compensation and carry no directional implication.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SEPN ▲ +16.88% at T+60d
NEUTRAL call ✓ call won +16.88% · α vs SPY +13.31% · entry $34.00 → $39.74
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
-1.56%
call -1.56% · α -2.43%
$33.47
settled 3mo ago
T+5d
+11.29%
call +11.29% · α +10.36%
$37.84
settled 3mo ago
T+20d
+3.47%
call +3.47% · α +3.89%
$35.18
settled 2mo ago
T+60d
+16.88%
call +16.88% · α +13.31%
$39.74
settled 4d ago

Price Chart

Loading chart...

Executive Summary

Two Septerna insiders (SVP Drug Discovery and Chief People Officer) sold a combined $148K in open-market shares after exercising options. The sales represent ~0.009% of the $1.6B market cap — trivial and consistent with routine tax/vesting-related transactions. No material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$148.0K
Insiders
2

Key Facts

  • Total open-market sales: $148K (0.009% of $1.6B market cap)
  • Both sales occurred on the same day as option exercises (tax/vesting pattern)
  • 7 directors received non-cash stock grants on 2026-06-26 (no economic value)
  • Insider activity is routine and immaterial relative to company size

Financial Impact

Negligible — $148K in insider sales is less than 0.01% of market cap

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SEPN-1783033258707
17 reports for SEPN
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +55.96%Apr 13, 2026
Filters
Rows
Reports for SEPN — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Press Release
NEUTRAL ★ 2/10
$38.51 $38.69▲ +0.47%▲ +0.69%$38.27 (−0.62%)
Sep 3, 2026
28d ago
3
NEUTRAL ★ 2/10
$36.75 $39.55▲ +7.62%▲ +8.83%$38.27 (+4.14%)
Aug 25, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$41.30 $37.68▼ −8.77%▼ −8.23%$38.27 (−7.34%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 7/10
$44.20 $40.52▲ +8.33%▲ +7.14%$38.27 (+13.42%)
Aug 14, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$44.20 $40.52▲ +8.33%▲ +7.14%$38.27 (+13.42%)
Aug 12, 2026
7w ago
144
BEARISH ★ 5/10
$45.14 $40.79▲ +9.64%▲ +7.67%$38.27 (+15.22%)
Aug 12, 2026
7w ago
144
BEARISH ★ 5/10
$45.14 $40.79▲ +9.64%▲ +7.67%$38.27 (+15.22%)
Aug 10, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$47.76 $43.80▼ −8.29%▼ −7.89%$38.27 (−19.87%)
Aug 10, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$47.76 $43.80▼ −8.29%▼ −7.89%$38.27 (−19.87%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$34.00 $37.84▲ +11.29%▲ +10.36%$38.27 (+12.56%)
Showing 10 of 17

US Market Status

Market Open — Closes in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 2, 2026